|
|
Volumn , Issue 95, 2006, Pages 157-169
|
|
Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates dyslipidemia, insulin resistance, and obesity for life-time.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LEPTIN;
NEUROPEPTIDE Y;
ANIMAL;
DRUG ANTAGONISM;
DYSLIPIDEMIA;
GENE THERAPY;
GENETICS;
HUMAN;
HYPOTHALAMUS;
INSULIN RESISTANCE;
METABOLIC SYNDROME X;
METABOLISM;
METHODOLOGY;
OBESITY;
PHYSIOLOGY;
REVIEW;
ANIMALS;
DYSLIPIDEMIAS;
GENE THERAPY;
HUMANS;
HYPOTHALAMUS;
INSULIN RESISTANCE;
LEPTIN;
METABOLIC SYNDROME X;
NEUROPEPTIDE Y;
OBESITY;
MLCS;
MLOWN;
|
|
EID: 33644847465
PISSN: 1023294X
EISSN: None
Source Type: Journal
DOI: 10.1007/3-7643-7417-9_12 Document Type: Review |
|
Times cited : (12)
|
|
References (52)
|
